Intravenous clodronate for the treatment of hypercalcaemia in breast cancer patients with bone metastases—A prospective randomised placebo-controlled multicentre study
- 31 May 1992
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (4-5), 890-893
- https://doi.org/10.1016/0959-8049(92)90143-p
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The Use of Clodronate in Disorders of Calcium and Skeletal Metabolism1Published by S. Karger AG ,2015
- COMPARISON OF THREE INTRAVENOUS BISPHOSPHONATES IN CANCER-ASSOCIATED HYPERCALCAEMIAThe Lancet, 1989
- Treatment of Tumor Hypercalcemia with ClodronatePublished by Springer Nature ,1989
- Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronateBone, 1988
- Clodronate. A randomized study in the treatment of cancer-related hypercalcemiaArchives of Internal Medicine, 1987
- The clinical course of bone metastases from breast cancerBritish Journal of Cancer, 1987
- Osteolytic bone metastases in breast carcinoma pathogenesis, morbidity and biphosphonate treatmentEuropean Journal of Cancer and Clinical Oncology, 1986
- Comparison of two parenteral diphosphonates in hypercalcemia of malignancyThe American Journal of Medicine, 1982